| Status | Study |
| Recruiting |
Study Name: Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant Condition: Intestinal Microbiome Febrile Neutropenia Date: 2017-03-08 Interventions: Drug: Piperacillin-tazobactam |
| Recruiting |
Study Name: Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Condition: Chemotherapy-induced Neutropenia Date: 2017-03-06 Interventions: Drug: Plinabulin Plinabulin (B |
| Not yet recruiting |
Study Name: Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer Condition: Febrile Neutropenia Date: 2017-02-24 Interventions: Drug: EC-18 oral administration Other Name: EC-18 so |
| Recruiting |
Study Name: Shared Health Information System for Febrile Neutropenia Condition: Febrile Neutropenia Solid Tumor Hematologic Neoplasms Date: 2017-02-20 Interventions: Device: NEUTROSIS evaluate a shared health information system (NEUTROSIS) for home-hospital management o |
| Recruiting |
Study Name: Study of Isavuconazole Prophylaxis in Adults With Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) and Neutropenia Condition: Acute Myeloid Leukemia Myelodysplastic Syndrome Date: 2017-01-11 Interventions: Drug: Isavuconazole Isavuconazole administered at a dose of 372 mg (i.e., 2 capsules, or 200 mg of Isavu |
| Not yet recruiting |
Study Name: Early Stoppage Versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients With Febrile Neutropenia, Before Recovery of Counts: -DALFEN Study Condition: Neutropenia, Febrile Pediatric Cancer Date: 2016-12-13 Interventions: Other: stoppage of antibiotics |
| Recruiting |
Study Name: PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia Condition: Lymphoma,Non-Hodgkin Date: 2016-11-19 Interventions: Drug: rhG-CSF regimen Patients |
| Completed |
Study Name: Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia Condition: Non-Interventional Study Date: 2016-11-03 Interventions: Other: Overall satisfaction questionnaires of home use of Nivestim |
| Not yet recruiting |
Study Name: Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Early- Stage BReast Cancer Patients Receiving Docetaxel and Cyclophosphamide (RECOVER) Condition: Neutropenia Breastcancer Date: 2016-10-27 Interventions: Drug: SPI-2012 Supplied in pre |
| Recruiting |
Study Name: Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnostic Assay Condition: Infection Neutropenia Date: 2016-09-19 |